Search Results 781-790 of 21549 for Inhibition
Patients with a history of clinical benefit from prior RAF inhibitor therapy, as judged by the investigator, will be allowed. Exclusion Criteria: Patients ...
For patients with a documented germ-line BRCA1/BRCA2 mutation who received an approved PARP inhibitor ... Oral, intravaginal, transdermal, progestin -only ...
... inhibition. If patients received BRAF and MEK inhibitor therapy in the metastatic setting, they are not eligible. Patient may have been treated with prior ...
Take certain medicines. These include monoamine oxidase inhibitors, neuroleptics and medicines that contain levodopa (Sinemet, Rytary, others). Have the muscle ...
... inhibitors, sulfonylureas, or dipeptidyl peptidase-4 (DPP4) inhibitors, insulin or peroxisome proliferator-activated receptor (PPAR)γ agonists (pioglitazone ...
Developing a new drug for women with resistance to aromatase inhibitors; Identifying mechanisms for why some people do not respond to endocrine treatment ...
Many types of antidepressants are available to treat depression, including: Selective serotonin reuptake inhibitors (SSRIs). Health care providers often start ...
Angiotensin-converting enzyme (ACE) inhibitors · Anxiety: A cause of high blood pressure? Arteriosclerosis / atherosclerosis · Artificial sweeteners: Any effect ...
Tau aggregation inhibitors and tau vaccines are currently being studied in clinical trials. Reducing inflammation. Alzheimer's causes chronic, low-level ...
... inhibitor (SSRI)/serotonin and norepinephrine reuptake inhibitor (SNRI) anti-depressants, cholinergic agonists, cholinesterase inhibitors, or complementary ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.